SCHEMBL6972986

SCHEMBL6972986

Cc1ccc2c(c1)CC(Br)C2=O

nearest known ligand 0.54

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
METAP1 P53582 5/20 0.54
ACHE P22303 3/20 0.47
HTR2A P28223 1/20 0.42
HTR2C P28335 1/20 0.42
HTR2B P41595 1/20 0.42
PARP10 Q53GL7 1/20 0.42
PARP11 Q9NR21 1/20 0.42
MAOB P27338 6/20 0.38
MAOA P21397 1/20 0.38
AADAT Q8N5Z0 1/20 0.37
ELANE P08246 1/20 0.37
CYP19A1 P11511 1/20 0.36
SRD5A1 P18405 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Dimethylformamide SCHEMBL7845290 0.89 METAP1 (0.52) METAP1ACHEHTR2AHTR2CHTR2B
SCHEMBL6974545 0.85 ACHE (0.66) METAP1ACHEHTR2AHTR2CHTR2B
SCHEMBL11828763 0.82 PARP10 (0.47) METAP1ACHEPARP10PARP11MAOB
SCHEMBL8555030 0.79 METAP1 (0.54) METAP1PARP10PARP11SRD5A1
SCHEMBL2484416 0.79 ACHE (0.73) METAP1ACHEHTR2AHTR2CHTR2B
SCHEMBL6239541 0.79 TDP1 (0.46) METAP1ACHEMAOBMAOA
SCHEMBL30666697 0.78 METAP1 (0.53) METAP1HTR2AHTR2CHTR2BAADAT
SCHEMBL30666881 0.78 ACHE (0.46) METAP1ACHEHTR2AHTR2CHTR2B
SCHEMBL14939019 0.78 METAP1 (0.54) METAP1ACHEHTR2AHTR2CHTR2B
SCHEMBL28110573 0.78 METAP1 (0.54) METAP1ACHEHTR2AHTR2CHTR2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4265613-A1 BENZENE RING COMPOUND AND USE THEREOF Nanjing Shijiang Medicine Technology Co., Ltd (CN) 2023-10-25 EP disclosed
CN-106132928-B Anil, the medical composition and its use containing the derivative 橘生药品工业株式会社 2019-03-29 CN disclosed
CN-1122666-C New 2,3-dioxide, indanol compounds, process for their preparation and pharmaceutical compositions containing them ADIR (FR) 2003-10-01 CN disclosed
EP-0906912-B1 Indanol derivatives, process for their preparation and pharmaceutical compositions containing them SERVIER LAB (FR) 2003-01-08 EP disclosed
US-6060487-A Indanol compounds ADIR ET COMPAGNIE (FR) 2000-05-09 US disclosed
US-5958927-A PSYCHOLOGICAL AND NERVOUS SYSTEM DISORDERS ADIR ET COMPAGNIE (FR) 1999-09-28 US disclosed
EP-0906912-A1 Indanol derivatives, process for their preparation and pharmaceutical compositions containing them ADIR ET COMPAGNIE (FR) 1999-04-07 EP disclosed
EP-0662971-B1 5H,10H-IMIDAZO[1,2-a]INDENO[1,2-e]PYRAZINE-4-ONE DERIVATIVES, PREPARATION THEREOF AND MEDICAMENTS CONTAINING THEM RHONE POULENC RORER SA (FR) 1998-05-13 EP disclosed
US-5677306-A ANTAGONIZING ALPHA-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLEPROPIONIC ACID RECEPTOR, USEFUL FOR TREATING ALL ISCHEMIAS RHONE-POULENC RORER S.A. (FR) 1997-10-14 US disclosed
EP-0662971-A1 DERIVATIVES OF 5H,10H-IMIDAZO 1,2-a]INDENO 1,2-e]PYRAZINE-4-ONE, PREPARATION THEREOF AND MEDICAMENTS CONTAINING THEM Aventis Pharma S.A. (FR) 1995-07-19 EP disclosed
WO-1994007893-A1 DERIVATIVES OF 5H,10H-IMIDAZO[1,2-a]INDENO[1,2-e]PYRAZINE-4-ONE, PREPARATION THEREOF AND MEDICAMENTS CONTAINING THEM RHONE-POULENC RORER S.A. (FR) 1994-04-14 WO disclosed
US-3932430-A Substituted indeno, naphtho and cyclohepta pyrazoles SANDOZ, INC. (US) 1976-01-13 US disclosed